Onxeo: Belinostat Abstracts for American Association for

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Apr 20, 2015 at 2:00 PM

Onxeo: Belinostat Abstracts for American Association for Cancer Research 2015

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, today announced that preclinical and clinical data on belinostat will be presented at the 2015 American Association for Cancer Research (AACR) Annual Meeting (April 18-22, 2015) in Philadelphia (Pennsylvania), USA. Preclinical and clinical abstracts involving belinostat will be featured at the AACR 2015. To be highlighted are especially abstracts no. 114 and 5480. Abstract no. 114 concerns the mass balance study of 14C-belinostat in patients with recurrent or progressive malignancy. The aim of the study is to evaluate the excretion (mass balance) and pharmacokinetics of belinostat and to further understand the drug’s metabolism. The study is a post-marketing requirement study set by the US Food and Drug Administration (FDA). The study’s top-line results show that the study was positively conducted. Abstract 5480 concerns the clinical toxicity of belinostat, which shows that belinostat has a good safety profile. The studies supporting these abstracts were conducted on belinostat in different cancer indications and have generated relevant and robust preclinical and clinical data on the product’s profile, alone or in combination with other chemotherapies. These first data will much help supporting and finalizing the best development plan for belinostat and already advocate for the selection of new promising orphan oncology indications. The involvement of the large number of investigators in these studies demonstrates the scientific and clinical interest on the product and is encouraging for the future potential of clinical sites to enroll. “Already registered and marketed in the US for the treatment of peripheral T -cell lymphoma, belinostat has furthermore a strong potential research focus and several potential cancer indications. The product’s development plan is being built based on these assets and perfectly fits with our strategy to build a robust and diversified pipeline focused on the orphan oncology”, comments Judith Greciet, CEO of Onxeo. Please see the abstracts, that are now available on AACR’s website (http://www.aacr.org/ (http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3 A %2F%2Fwww.aacr.org%2F&esheet=51083533&newsitemid=0&lan=en -US&anchor=http%3A%2F%2Fwww.aacr.org%2F&index=1&md5=255bbda18e917fd7bec9988d7c2c 0 94e)). About the AACR The American Association for Cancer Research (AACR) (http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.aacr . org%2F%3Ffdn&esheet=51083533&newsitemid=0&lan=en -US&anchor=American+Association+for+Cancer+Research+%28AACR%29&index=2&md5=0e870 8 8ed53fbc9d2943461ec6eaf4cb) is the first and largest cancer research organization in the world. The Philadelphia-based nonprofit organization was founded in 1907 by a group of 11 physicians and scientists interested in research "to further the investigation and spread the knowledge of cancer." The mission of the AACR is to understand, prevent, diagnose, treat, and cure cancer by promoting research, education, communication, and collaboration. To that end, the AACR focuses on every facet of high-quality, innovative cancer research. About Onxeo Onxeo has the vision to become a global leader and pioneer in oncology, with a focus on orphan or rare cancers, through developing innovative therapeutic alternatives to “make the difference”. The Onxeo teams are determined to develop innovative medicines to provide patients with hope and significantly improve their lives. Key orphan oncology products at the advanced development stage are: Livatag® (Doxorubicin Transdrug™): Phase III in hepatocellular carcinoma Validive® (Clonidine Lauriad®): Phase II in severe oral mucositis: Positive preliminary top-line results Beleodaq® (belinostat): registered in the US in peripheral T-cell lymphoma For more information, visit the website www.onxeo.com (http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3 A %2F%2Fwww.onxeo.com&esheet=51083533&newsitemid=0&lan=en -US&anchor=www.onxeo.com&index=3&md5=dea69caa41ceecbf9ed6ab70f451fab2) Disclaimer This communication expressly or implicitly contains certain forward-looking statements concerning Onxeo and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Onxeo to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Onxeo is providing this communication as of this date and does not undertake to update any forward -looking statements contained herein as a result of new information, future events or otherwise. For a discussion of risks and uncertainties which could cause actual results, financial condition, performance or achievements of Onxeo to differ from those contained in the forward-looking statements, please refer to the Risk Factors ("Facteurs de Risque") section of the 2014 Reference Document filed with the AMF on April 14, 2015, which is available on the AMF website (http://www.amf -france.org (http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww . amf-france.org&esheet=51083533&newsitemid=0&lan=en -US&anchor=http%3A%2F%2Fwww.amf -france.org&index=4&md5=5f3f446854423b3cd961f9a02d21b999)) or on the company’s website (www.onxeo.com (http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2F w ww.onxeo.com&esheet=51083533&newsitemid=0&lan=en -US&anchor=www.onxeo.com&index=5&md5=716249535a0099bfa2520c22eb91824f)). Contacts : Judith Greciet, CEO j.greciet@onxeo.com Nicolas Fellmann, CFO n.fellmann@onxeo.com +33 1 45 58 76 00 or Caroline Carmagnol / Sophie Colin – Alize RP onxeo@alizerp.com +33 6 64 18 99 59 / +33 1 44 54 36 62

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IEHP's Wellness Center Launch Faces Delay in California

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Where Winds Meet Celebrates 1st Anniversary With New Region

A Staggering Universe Deepens: Hutuo's Introduction Just when you think you've seen it all, NetEase Games and Everstone Studio go and launch Hutuo, a compelling addition to the already sprawling universe of Where Winds Meet. On the occasion of its first global anniversary, this epic Wuxia ARPG throws players into the mud-soaked, steel-clashing chaos of a warzone, testing...

Custom Upholstered Furniture: Comfort Built to Last

Rethinking Furniture Comfort: Not Just a Luxury Diving into the world of custom upholstered furniture with insights from Randy Marohn is like finding a cheat sheet for comfort. Seriously, it ain't just about plush cushions or slick fabrics—it's a bonafide science. Marohn, from Sans Furniture Inc. in good ol’ Hamburg, NY, unfolds a tale of intentional design and...

Sports Clock Radio: A Game Time Enthusiast's Dream

A New Gadget for the Diehard Fan Fanatics, gather 'round. There's an innovation rolling out that's looking to marry the good old alarm clock radio with the rush of game day fever! Over in Pittsburgh, an inventor's cooking up something that every loyal sports fan might soon find irresistible—a Sports Clock Radio, bringing the stadium experience to your living room or...

Gemmy's Holiday Lights: Bright Ideas for 2026

By Hannah Lewis Updated Nov 13, 2026 Category News Views 124

Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...

Later's NYC Summit Reinvents Social Commerce Game Plan

Creators and Corporates Collide Imagine this: an NYC stage not adorned with Broadway's finest, but with digital maestros steering a new age in social commerce. That's what Later is betting on with their Creator Live summit, debuting in the bustling heart of New York City. We're talking about influencers not just as Instagram stars, but as key players in a $480 billion...

Choosing Expert European Auto Repair: Key Insights

The Perks of Specialist Knowledge Ever get the feeling your local auto shop doesn't always cut it when your sleek BMW or classy Mercedes needs a tweak? You're not alone. Specifically, for those driving around Alpharetta, European vehicles demand not just routine check-ups but specialist hands. Much like how you wouldn't hand your luxury timepiece to the shop down the...

Celebrating Ted Turner's Legacy at the United Nations

Ted Turner's Unyielding Vision Celebrated at UN Gala Here we are, talking about Ted Turner, a guy who truly put his money where his mouth was. Not just another rich cat content with the status quo, he dropped a $1 billion bombshell in 1997 on the United Nations to shake up how the world's problems could be tackled. And last week, on November 9, notable bigwigs of the...

BETR Investors Face Action: Nov. 20 Deadline Nears

High Stakes for BETR Shareholders If you're holding shares in Better Home & Finance Holding Company, right now might feel like you're at a craps table with emptying pockets. BETR, trading under NASDAQ, has become the center of a legal hurricane, with investors eyeing the November 20th deadline to join a securities class action led by Hagens Berman. The class period in...

Morgan County, IN: An Oasis for Balanced Living

Why Morgan County? A Question for Homebuyers Ever wondered what makes Morgan County, IN, such a hot ticket for folks looking to escape the daily grind of big city life? Rachel Blacklidge, real estate wizard and hometown hero, lays it all out in a way even the most city-bound among us can appreciate. Small-Town Vibes, Big-City Access Let’s face it—sometimes the chaos...